Patents by Inventor Zishan Haroon

Zishan Haroon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF TREATING OR AMELIORATING SKIN CONDITIONS WITH A MAGNETIC DIPOLE STABILIZED SOLUTION
    Publication number: 20220079978
    Abstract: The present invention is directed to methods for treating or ameliorating skin conditions, diabetic conditions, cardiovascular conditions, cancer, infections or metal poisoning, enhancing performance, or providing nutritional support, comprising administering to a subject in need thereof compositions comprising a magnetic dipole stabilized solution (MDSS). The MDSS solution may include additional components and can be provided in a kit.
    Type: Application
    Filed: November 24, 2021
    Publication date: March 17, 2022
    Applicant: REVEN PHARMACEUTICALS, INC.
    Inventors: Peter Lange, Brian Denomme, Henk Van Wyk, Mariette Van Wyk, Tracy L. Krebs, Sezgin Ozgur, Zishan Haroon
  • Method of treating or ameliorating skin conditions with a magnetic dipole stabilized solution
    Patent number: 11202798
    Abstract: The present invention is directed to methods for treating or ameliorating skin conditions, diabetic conditions, cardiovascular conditions, cancer, infections or metal poisoning, enhancing performance, or providing nutritional support, comprising administering to a subject in need thereof compositions comprising a magnetic dipole stabilized solution (MDSS). The MDSS solution may include additional components and can be provided in a kit.
    Type: Grant
    Filed: December 20, 2017
    Date of Patent: December 21, 2021
    Assignee: REVEN PHARMACEUTICALS, INC.
    Inventors: Peter Lange, Brian Denomme, Henk Van Wyk, Mariette Van Wyk, Tracy L. Krebs, Sezgin Ozgur, Zishan Haroon
  • METHOD OF TREATING OR AMELIORATING SKIN CONDITIONS WITH A MAGNETIC DIPOLE STABILIZED SOLUTION
    Publication number: 20180243332
    Abstract: The present invention is directed to methods for treating or ameliorating skin conditions, diabetic conditions, cardiovascular conditions, cancer, infections or metal poisoning, enhancing performance, or providing nutritional support, comprising administering to a subject in need thereof compositions comprising a magnetic dipole stabilized solution (MDSS). The MDSS solution may include additional components and can be provided in a kit.
    Type: Application
    Filed: December 20, 2017
    Publication date: August 30, 2018
    Applicant: REVEN PHARMACEUTICALS, INC.
    Inventors: Peter Lange, Brian Denomme, Henk Van Wyk, Mariette Van Wyk, Tracy L. Krebs, Sezgin Ozgur, Zishan Haroon
  • Methods of treating or ameliorating skin conditions with a magnetic dipole stabilized solution
    Patent number: 9867849
    Abstract: The present invention is directed to methods for treating or ameliorating skin conditions, diabetic conditions, cardiovascular conditions, cancer, infections or metal poisoning, enhancing performance, or providing nutritional support, comprising administering to a subject in need thereof compositions comprising a magnetic dipole stabilized solution (MDSS). The MDSS solution may include additional components and can be provided in a kit.
    Type: Grant
    Filed: January 4, 2017
    Date of Patent: January 16, 2018
    Assignee: REVEN PHARMACEUTICALS, INC.
    Inventors: Peter Lange, Brian Denomme, Henk Van Wyk, Mariette Van Wyk, Tracy L. Krebs, Sezgin Ozgur, Zishan Haroon
  • METHODS OF TREATING OR AMELIORATING SKIN CONDITIONS WITH A MAGNETIC DIPOLE STABILIZED SOLUTION
    Publication number: 20170112872
    Abstract: The present invention is directed to methods for treating or ameliorating skin conditions, diabetic conditions, cardiovascular conditions, cancer, infections or metal poisoning, enhancing performance, or providing nutritional support, comprising administering to a subject in need thereof compositions comprising a magnetic dipole stabilized solution (MDSS). The MDSS solution may include additional components and can be provided in a kit.
    Type: Application
    Filed: January 4, 2017
    Publication date: April 27, 2017
    Applicant: REVEN PHARMACEUTICALS, INC.
    Inventors: Peter Lange, Brian Denomme, Henk Van Wyk, Mariette Van Wyk, Tracy L. Krebs, Sezgin Ozgur, Zishan Haroon
  • Methods of treating or ameliorating skin conditions with a magnetic dipole stabilized solution
    Patent number: 9572810
    Abstract: The present invention is directed to methods for treating or ameliorating skin conditions, diabetic conditions, cardiovascular conditions, cancer, infections or metal poisoning, enhancing performance, or providing nutritional support, comprising administering to a subject in need thereof compositions comprising a magnetic dipole stabilized solution (MDSS). The MDSS solution may include additional components and can be provided in a kit.
    Type: Grant
    Filed: September 4, 2013
    Date of Patent: February 21, 2017
    Assignee: REVEN PHARMACEUTICALS, INC.
    Inventors: Peter Lange, Brian Denomme, Henk Van Wyk, Mariette Van Wyk, Tracy L. Krebs, Sezgin Ozgur, Zishan Haroon
  • Synthesis and use of glycoside derivatives of propofol
    Patent number: 9023813
    Abstract: The present invention relates to methods and compositions for the synthesis, production, and use of pro-drug propofol analogs. This invention relates to a method for the production of a broad group of glycosylated propofol carbohydrate derivatives.
    Type: Grant
    Filed: April 9, 2012
    Date of Patent: May 5, 2015
    Assignee: Nutek Pharma Ltd.
    Inventors: Brian Shull, John Baldwin, Ramesh Gopalaswamy, Zishan Haroon
  • Glycosylated acetaminophen pro-drug analogs
    Patent number: 8722864
    Abstract: The present invention relates to methods and compositions for the synthesis, production, and use of pro-drug analogs of the analgesic acetaminophen. This invention relates to a method for the production of a broad group of glycosides of acetaminophen derivatives.
    Type: Grant
    Filed: July 14, 2011
    Date of Patent: May 13, 2014
    Assignee: Nutek Pharma Ltd.
    Inventors: Brian Shull, John Baldwin, Ramesh Gopalaswamy, Zishan Haroon
  • Use of cytokine receptors as biomarkers and therapeutic targets in human cancer
    Patent number: 8617844
    Abstract: Nucleic acids encoding erythropoietin receptor isoforms are described, as well as the encoded isoforms, methods of detecting the same, and methods of screening for and treating cancer.
    Type: Grant
    Filed: August 27, 2012
    Date of Patent: December 31, 2013
    Assignee: Duke University
    Inventors: Murat O. Arcasoy, Zishan A. Haroon
  • USE OF NOVEL CYTOKINE RECEPTORS AS BIOMARKERS AND THERAPEUTIC TARGETS IN HUMAN CANCER
    Publication number: 20130344497
    Abstract: Nucleic acids encoding erythropoietin isoforms are described herein, as well as the encoded isoforms, methods of detecting the same, and methods of screening for and treating cancer.
    Type: Application
    Filed: September 4, 2013
    Publication date: December 26, 2013
    Applicant: Duke University
    Inventors: Murat O. Arcasoy, Zishan A. Haroon
  • GLYCOSYLATED ACETAMINOPHEN PRO-DRUG
    Publication number: 20130217640
    Abstract: The present invention relates to methods and compositions for the synthesis, production, and use of pro-drug analogs of the analgesic acetaminophen. This invention relates to a method for the production of a broad group of glycosides of acetaminophen derivatives.
    Type: Application
    Filed: July 18, 2011
    Publication date: August 22, 2013
    Inventors: Brian Shull, John Baldwin, Ramesh Gopalaswamy, Zishan Haroon
  • USE OF NOVEL CYTOKINE RECEPTORS AS BIOMARKERS AND THERAPEUTIC TARGETS IN HUMAN CANCER
    Publication number: 20120329065
    Abstract: Nucleic acids encoding erythropoietin isoforms are described herein, as well as the encoded isoforms, methods of detecting the same, and methods of screening for and treating cancer.
    Type: Application
    Filed: August 27, 2012
    Publication date: December 27, 2012
    Inventors: Murat O. Arcasoy, Zishan A. Haroon
  • Synthesis And Use Of Glycoside Pro-Drug Analogs
    Publication number: 20120295866
    Abstract: The present invention relates to methods and compositions for the synthesis, production, and use of pro-drug analogs. This invention relates to a method for the production of a broad group of glycosylated drugs, including but not limited to propofol, acetaminophen, and camptothecin carbohydrate derivatives.
    Type: Application
    Filed: April 9, 2012
    Publication date: November 22, 2012
    Inventors: Brian Shull, John Baldwin, Ramesh Gopalaswamy, Zishan Haroon
  • Synthesis And Use Of Glycoside Derivatives of Propofol
    Publication number: 20120264702
    Abstract: The present invention relates to methods and compositions for the synthesis, production, and use of pro-drug propofol analogs. This invention relates to a method for the production of a broad group of glycosylated propofol carbohydrate derivatives.
    Type: Application
    Filed: April 9, 2012
    Publication date: October 18, 2012
    Inventors: Brian Shull, John Baldwin, Ramesh Gopalaswamy, Zishan Haroon
  • Use of cytokine receptors as biomarkers and therapeutic targets in human cancer
    Patent number: 8273551
    Abstract: Nucleic acids encoding erythropoietin receptor isoforms are described, as well as the encoded isoforms, methods of detecting the same, and methods of screening for and treating cancer.
    Type: Grant
    Filed: June 27, 2011
    Date of Patent: September 25, 2012
    Assignee: Duke University
    Inventors: Murat O. Arcasoy, Zishan A. Haroon
  • Glycosylated Acetaminophen Pro-Drug Analogs
    Publication number: 20120022012
    Abstract: The present invention relates to methods and compositions for the synthesis, production, and use of pro-drug analogs of the analgesic acetaminophen. This invention relates to a method for the production of a broad group of glycosides of acetaminophen derivatives.
    Type: Application
    Filed: July 14, 2011
    Publication date: January 26, 2012
    Inventors: Brian Shull, John Baldwin, Ramesh Gopalaswamy, Zishan Haroon
  • USE OF NOVEL CYTOKINE RECEPTORS AS BIOMARKERS AND THERAPEUTIC TARGETS IN HUMAN CANCER
    Publication number: 20110256543
    Abstract: Nucleic acids encoding erythropoietin isoforms are described herein, as well as the encoded isoforms, methods of detecting the same, and methods of screening for and treating cancer.
    Type: Application
    Filed: June 27, 2011
    Publication date: October 20, 2011
    Inventors: Murat O. Arcasoy, Zishan A. Haroon
  • USE OF NOVEL CYTOKINE RECEPTORS AS BIOMARKERS AND THERAPEUTIC TARGETS IN HUMAN CANCER
    Publication number: 20100092975
    Abstract: Nucleic acids encoding erythropoietin isoforms are described herein, as well as the encoded isoforms, methods of detecting the same, and methods of screening for and treating cancer.
    Type: Application
    Filed: August 17, 2009
    Publication date: April 15, 2010
    Inventors: Murat O. Arcasoy, Zishan A. Haroon
  • Use of cytokine receptors as biomarkers and therapeutic targets in human cancer
    Patent number: 7598057
    Abstract: Nucleic acids encoding erythropoietin receptor isoforms are described, as well as the encoded isoforms, methods of detecting the same, and methods of screening for and treating cancer.
    Type: Grant
    Filed: August 30, 2006
    Date of Patent: October 6, 2009
    Assignee: Duke University
    Inventors: Murat O. Arcasoy, Zishan A. Haroon
  • Tumor Boundary Imaging
    Publication number: 20090074672
    Abstract: Tumor boundaries and wound healing are optically imaged by cross-linking a fluorescently-labeled tissue transglutaminase substrate into extracellular matrix.
    Type: Application
    Filed: September 17, 2008
    Publication date: March 19, 2009
    Inventors: Gregory W. Faris, Chia-Pin Pan, Zishan Haroon